60
Participants
Start Date
March 31, 1997
immunoscintigraphy
technetium Tc 99m epratuzumab
Istituto Europeo Di Oncologia, Milan
Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore
Nuclear Physicians Ltd., Cuyahoga Falls
University of Texas- Houston Medical School, Houston
Cedars-Sinai Medical Center, Los Angeles
Innsbruck Universitaetsklinik, Innsbruck
Lund University Hospital, Lund
Centre Hospitalier Universitaire Vaudois, Lausanne
Lead Sponsor
Gilead Sciences
INDUSTRY